K4-MA-SE-TX-L1.jpg
Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
April 24, 2024 07:08 ET | Keiretsu Forum Mid-Atlantic
Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly announce their sponsorship of Quix Labs at the upcoming Innovation Funders Showcase.
22157.jpg
Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 with Abbott, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating
April 24, 2024 07:06 ET | Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Europe In-Vitro Diagnostics (IVD) Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.Europe's in-vitro...
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
April 24, 2024 07:05 ET | Travere Therapeutics, Inc.
Travere and CSL Vifor announce EC approval of FILSPARI (sparsentan) for treatment of IgAN, 1st non-immunosuppressive treatment for IgAN approved in Europe
Aðalfundur Klappa Gr
Aðalfundur Klappa Grænna Lausna hf. 14. maí 2024 - leiðréttar ályktunartillögur stjórnar
April 24, 2024 07:02 ET | Klappir Grænar Lausnir hf.
Aðalfundur Klappa Grænna Lausna hf. 14. maí 2024 Meðfylgjandi eru leiðréttar ályktunartillögur stjórnar.  Leiðréttingin er vegna 4. dagskrárliðar og varðar ákvörðun um meðferð hagnaðar félagsins....
Hookipa Pharma Logo Square.png
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
April 24, 2024 07:01 ET | HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary...
rogers-logo.png
Rogers Communications Reports First Quarter 2024 Results
April 24, 2024 07:00 ET | Rogers Communications, Inc.
Reports nine straight quarters of industry-leading growthReaffirms industry-leading 2024 financial guidance More Canadians continue to choose Rogers over any other carrier 124,000...
22157.jpg
France Data Center Market Investment Analysis & Growth Opportunity 2024-2029: Digital Realty, CloudHQ and Scaleaway Announced Investments in the French Data Center Industry in 2023
April 24, 2024 07:00 ET | Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "France Data Center Market - Investment Analysis & Growth Opportunity 2024-2029" report has been added to ResearchAndMarkets.com's offering.The...
怪兽logo_2.png
Smart Share Global Limited Files Its Annual Report on Form 20-F
April 24, 2024 07:00 ET | Smart Share Global Limited
SHANGHAI, April 24, 2024 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today...
NEW ATAI-Logo_Primary.png
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
April 24, 2024 07:00 ET | atai Life Sciences
The BPL-003 Phase 2a trial is an open-label study investigating BPL-003 as both monotherapy and adjunctive to SSRIs in patients with Treatment Resistant Depression.Initial results from the recently...